EPA and DHA Market Size & Share Analysis – Growth Trends & Forecasts (2025 – 2030)
The Global EPA & DHA Market Report is Segmented by Type (Eicosapentaenoic Acid and Docosahexaenoic Acid), Source (Fish Oil, Algae Oil, Krill Oil, and Other Sources); Application (Infant Formulae, Dietary Supplements, Fortified Food and Beverages, Pharmaceuticals, and Other Applications); and Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa). The Report Offers Market Size and Values in (USD) During the Forecast Period for the Above Segments.
EPA and DHA Market Size & Share Analysis – Growth Trends & Forecasts (2025 – 2030)
EPA & DHA Market Size
| Study Period | 2019 – 2030 |
| Market Size (2025) | USD 2.06 Billion |
| Market Size (2030) | USD 2.96 Billion |
| CAGR (2025 – 2030) | 7.51 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | Asia-Pacific |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
.webp "EPA And DHA Market Major Players"){kind=logo}
EPA & DHA Market Analysis
The EPA And DHA Market size is estimated at USD 2.06 billion in 2025, and is expected to reach USD 2.96 billion by 2030, at a CAGR of 7.51% during the forecast period (2025-2030).
The market for EPA and DHA is primarily driven by increasing awareness regarding potential health benefits associated with fatty acids. Furthermore, the rising incidences of chronic conditions, such as high blood pressure, diabetes, and cardiovascular disease, augment the demand for EPA and DHA ingredients. These algae omega-3 ingredients help improve heart health by lowering triglycerides, raising good cholesterol levels, and protecting the heart from irregular heart rhythms. They also support muscle recovery, reduce the risk of certain cancers, and aid normal brain and eye development in babies. Moreover, health organizations and regulatory bodies worldwide, such as the Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA), recognize the health benefits of EPA and DHA and provide dietary recommendations and guidelines to promote their consumption. Such regulatory support contributes to the growth of the EPA and DHA market by fostering consumer confidence and awareness. Besides this, key companies focus on mergers and acquisitions, expanding their product portfolio, and launching new products to maintain their position in the market. For instance, in February 2024, Epax launched a full-spectrum oil with a combination of omega 3, 9, and 11, which has particular potential for skin health supplements.
EPA & DHA Market Trends
Increasing Awareness Of Health Benefits Associated With EPA And DHA
The increasing consumer preference for tailored health solutions has increased demand for DHA-infused food and feed products. As individuals seek nutritionally enriched options, there is a noticeable transition toward products that offer versatile health benefits derived from DHA. Omega-3 supplements containing DHA provide a convenient way for individuals to boost their intake of beneficial fatty acids, supporting overall health and well-being. The increased prevalence of lifestyle diseases and consumers seeking preventive healthcare measures further drive the intake of omega supplements. Moreover, health organization recommendations highlighting the optimal intake of DHA for heart health and overall well-being significantly shape consumer preferences and market dynamics. For instance, the Global Organization for DHA Omega-3s (GOED), a non-profit trade association for omega-3 oils, established a daily recommendation for DHA and EPA intake of 700-1000 mg for lactating or pregnant women, 500 mg for healthy adults, and more than 1g depending on additional health conditions.
Asia-Pacific Holds a Significant Share
Asia-Pacific has been leading the market studied, owing to the high consolidated production and consumption in countries like China and Japan. Consumers in this region tend to source omega-3 majorly from fish-rich diets rather than algae-based products. According to a survey conducted by the Japan Fisheries Association in 2022, a majority of 51.2 percent of respondents ate seafood because of the omega-3 fatty acids DHA and EPA contained in fish meat that the body cannot produce. Over 50 percent of respondents believed that DHA and EPA helped in cancer prevention, lifestyle-related diseases, and dementia. Moreover, there has also been a growing demand for omega supplements for kids due to increasing awareness among parents about the crucial role of EPA and DHA in brain development and other vital functions. China is the leading country in the global infant nutrition market with nearly 50 % market share in value, according to the Lactalis ingredients company reports as of 2023. Infant formulae, followed by dietary supplements, are two major Chinese EPA and DHA applications.
EPA & DHA Industry Overview
The Global EPA and DHA market is fragmented and comprises local and international competitors. The players compete using various strategies, ranging from expanding their production facilities to maintaining food safety guidelines. They also focus on partnerships and product innovations to increase market share and consumer base in various regions. Corbion NV, KD Pharma Group, Polaris SA, DSM-Firmenich, and Neptune Wellness Solutions are the major companies among other key market players.
EPA & DHA Market Leaders
- Corbion N.V.
- Koninklijke DSM NV
- KD Pharma Group
- Polaris SA
- Neptune Wellness Solutions
- *Disclaimer: Major Players sorted in no particular order
EPA & DHA Market News
- March 2024: DSM-Firmenich partnered with SCN BestCo to launch omega-3 gummies with EPA and DHA ingredients.
- March 2024, Epax, a wholly owned subsidiary of Norwegian company Pelagia AS, a prominent global brand of premium omega-3 ingredients, invested USD 40 million in a state-of-the-art distillation facility to implement its next-level distillation technology for ultra-concentrated omega-3 production.
- In February 2024, Epax launched a full-spectrum oil with a combination of omega 3, 9, and 11, which has particular potential for skin health supplements. EPAX Omega 3-9-11 is rich in Omega-3 EPA and DHA—long-chain polyunsaturated fatty acids (LC-PUFAs), which are well known for their benefits in heart and brain health.
EPA & DHA Industry Segmentation
EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are long-chain omega-3 fatty acids from various vegetable and animal sources.
The global EPA and DHA market study is segmented by type, source, application, and geography. By type, the market studied is segmented into eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Based on the source, the market studied is segmented into fish oil, algae oil, krill oil, and other sources. By application, the study covers infant formulae, dietary supplements, fortified food and beverages, pharmaceuticals, and other applications. Furthermore, the report takes into consideration the market in established and emerging economies of North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. For each segment, the market sizing and forecasts have been done on the basis of value (in USD).
| Type | Eicosapentaenoic Acid (EPA) | |
| Docosahexaenoic Acid (DHA) | ||
| Source | Fish Oil | |
| Algae Oil | ||
| Krill Oil | ||
| Other Sources | ||
| Application | Infant Formulae | |
| Dietary Supplements | ||
| Fortified Food and Beverages | ||
| Pharmaceuticals | ||
| Other Applications | ||
| Geography | North America | United States |
| Mexico | ||
| Canada | ||
| Rest of North America | ||
| Geography | Europe | Spain |
| United Kingdom | ||
| Germany | ||
| France | ||
| Russia | ||
| Italy | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| Rest of Asia-Pacific | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America | ||
| Geography | Middle East and Africa | United Arab Emirates |
| South Africa | ||
| Rest of Middle East and Africa |
EPA & DHA Market Research FAQs
The EPA And DHA Market size is expected to reach USD 2.06 billion in 2025 and grow at a CAGR of 7.51% to reach USD 2.96 billion by 2030.
In 2025, the EPA And DHA Market size is expected to reach USD 2.06 billion.
Corbion N.V., Koninklijke DSM NV, KD Pharma Group, Polaris SA and Neptune Wellness Solutions are the major companies operating in the EPA And DHA Market.
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
In 2025, the Asia-Pacific accounts for the largest market share in EPA And DHA Market.
In 2024, the EPA And DHA Market size was estimated at USD 1.91 billion. The report covers the EPA And DHA Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the EPA And DHA Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.